You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (vi) Distribution of new inpatient clients by primary drug for each age group

Substance	<15	15-19	20-24	25-29	30-34	35-39	40-44	45+	Age known	Age not known
Opiates	16.6	43.7	61.9	64.8	51.5	53.4	33.8	25.2	2154	82
Cocaine	1.4	3.4	6.2	5.7	9.2	5.8	2.9	2.7	199	8
Stimulants	14.2	23.5	14.2	10.7	12.8	12.6	2.9	0.9	830	42
Hypnotics and sedatives	2.2	2.0	3.7	8.1	13.3	20.4	39.7	53.2	262	31
Hallucinogens	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	9	0
Volatile substances	12.7	4.7	1.8	1.3	1.0	0.0	0.0	0.0	216	4
Cannabis	40.2	20.8	9.9	6.3	6.1	2.9	5.9	0.9	877	20
Other substances	12.1	1.7	2.2	3.1	6.1	4.9	14.7	17.1	204	4
Total	717	2106	1067	383	196	103	68	111	4751	191

Notes:

Countries reporting data: BG, CZ, DK, IE, EL, CY, RO, SK, FI, SE, TR

The number of treatment clients in each country is listed in [Table TDI-7].

See also 'TDI-108-New inpatient age at first use and primary drug.xls' on distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

2006 Reitox national reports - Table TDI inpatient treatment centres.